Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one

ConferenceMedicine and clinical research · Munich, Germany

European Lung Cancer Congress 2027

The European Lung Cancer Congress 2027, ESMO’s thoracic oncology congress, takes place at ICM Munich from 17 to 20 March 2027. This guide covers areas consistent with the congress scope, readiness checks for abstracts, and what to consider before the abstract deadline of 12 January 2027 listed by ESMO, with late-breaking abstracts due 16 February 2027.

Pubrica InsightsEditorial team, reviewed by a subject specialist
Next deadline
12 January 2027
Last checked
10 November 2026
Organiser
European Society for Medical Oncology
Sources
1
Submit an abstract

Key dates

Abstract deadline
12 January 2027
Full paper deadline
Abstracts only, or not stated
Conference dates
17 March 2027 – 20 March 2027
Details last checked
10 November 2026
Submit an abstract

About the conference

Conference
European Lung Cancer Congress 2027
Organiser
European Society for Medical Oncology
Venue
Munich, Germany
Scope
ESMO's thoracic oncology congress at ICM Munich; ESMO lists 12 January 2027 as the abstract deadline, with late-breaking abstracts due 16 February 2027.
Submission types
Abstracts; confirm formats and word limits on the official page

Topics consistent with the programme

  • Targeted therapies and immunotherapy in non-small cell lung cancer
  • Small cell lung cancer and other thoracic malignancies
  • Lung cancer screening and early detection
  • Surgery and radiotherapy in thoracic oncology
  • Molecular testing and biomarkers in lung cancer
  • Supportive care and quality of life in thoracic cancers

Based on the published scope; the official page sets out the full themes and requirements.

Is your work a fit? Check before you submit

  1. The work addresses lung cancer or other thoracic malignancies.
  2. The abstract reports original findings with clear methods and conclusions.
  3. Clinical data are reported with ethical approval and appropriate reporting standards.
  4. The abstract category and rules have been confirmed on the official ESMO abstract page.
  5. The abstract is complete, approved by all co-authors and submitted before 12 January 2027, or by 16 February 2027 if eligible as late-breaking.

Why This Conference Matters

Thoracic oncology has changed considerably with targeted therapies, immunotherapy and screening programmes, yet lung cancer remains a major cause of cancer death. The European Lung Cancer Congress brings together oncologists, surgeons, radiation oncologists, pulmonologists and researchers with a shared focus on thoracic cancers. Presenting gives authors access to a specialist multidisciplinary audience and the opportunity to discuss findings relevant to practice.

Who Should Submit

Academic backgrounds

  • Medical oncology
  • Thoracic surgery
  • Radiation oncology
  • Pulmonology
  • Pathology and molecular diagnostics

Institutions and sectors

  • Cancer centres and university hospitals
  • Pharmaceutical and biotechnology companies
  • Screening programmes and public health bodies
  • Oncology research institutes

What Reviewers Typically Value

  1. Original clinical or translational data relevant to thoracic cancer care.
  2. Robust methods with transparent reporting of outcomes.
  3. Biomarker and molecular studies with clinical implications.
  4. Findings addressing access to testing, screening or treatment.

Ideas You Could Develop

Outcomes of a screening programmeA study reporting stage distribution and outcomes among cancers detected through a lung cancer screening programme.
Immunotherapy in older patientsA real-world cohort study of immunotherapy outcomes and toxicity in older patients with advanced lung cancer.
Access to molecular testingA study examining rates and turnaround times of molecular testing and their effect on treatment selection.

Your Plan to the Deadline

A suggested schedule working back from 12 January 2027. Adjust it to the stage your work has reached.

  1. By 1 Dec 2026

    Open the official call for abstracts; confirm the tracks, word limit, format and author rules.

  2. By 15 Dec 2026

    Agree the key result, the authors and the presenting author.

  3. By 29 Dec 2026

    Draft the structured abstract to the word limit, with results stated as numbers.

  4. By 5 Jan 2027

    Circulate to co-authors and an independent reader; revise.

  5. By 10 Jan 2027

    Final checks: title, author affiliations, conflicts of interest and track selection.

  6. By 12 Jan 2027

    Submit through the official abstract system before the deadline.

What you gain

  • Feedback from peers working on the same questions.
  • A citable abstract or proceedings paper.
  • Contacts for collaboration, employment and future funding.
  • A step towards a full journal article.

What happens after you submit

  1. Acknowledgement: the abstract system confirms receipt; keep the submission number.
  2. Review: the scientific committee scores abstracts against the track criteria.
  3. Decision: accepted abstracts are assigned to an oral, poster or e-poster session.
  4. Registration: presenting authors usually must register by a stated date.
  5. Publication: accepted abstracts or papers may appear in the conference proceedings or journal supplement.

What the Organisers Are Looking For

ESMO invites abstracts across thoracic oncology research and care. Organisers are likely to look for original, well-reported clinical and translational work relevant to practice. ESMO lists 12 January 2027 as the abstract deadline, with late-breaking abstracts due 16 February 2027. Authors should confirm categories and rules on the official ESMO abstract page.

Read the official pageThis guide summarises the opportunity. Confirm deadlines, eligibility and requirements on the official page before you plan your work, and record the date you checked it.Open the official page

FAQs

Questions Researchers Ask

The next published deadline is 12 January 2027. Dates can change, so confirm them on the official page before you plan your work.

Late-breaking rounds are typically intended for important data that were not available by the regular deadline, and criteria can be strict. Authors should review the official ESMO abstract page to confirm eligibility before planning a submission for 16 February 2027.

The official page lists abstract submission; check it for any full paper or proceedings option.

Yes. Pubrica’s specialists can review, write, edit and format your abstract, paper, poster or slides. You remain the author and the person responsible for the submission.

Sources

  1. European Society for Medical Oncology. (2026). European Lung Cancer Congress 2027. Retrieved 10 November 2026, from https://www.esmo.org/meeting-calendar/european-lung-cancer-congress-2027/abstracts

How to cite this page

Pubrica Insights. (2026). European Lung Cancer Congress 2027. Pubrica. https://pubrica.com/insights/calls-and-conferences/european-lung-cancer-congress-2027/

ELCC 2027Next deadline 12 January 2027

Official page
Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.